Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Corneal neovascularization (CNV) is one of the major causes of severe disorders in ocular surface. Subconjunctival administration provides a localized and effective delivery of anti-angiogenic agents to inhibit neovascularization. In the present study, the ABA triblock copolymer of poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene glycol)-block-poly(D,L-lactic-co-glycolic acid) (PLGA-PEG-PLGA) was used as a sustained drug delivery carrier for metformin (MET) and levofloxacin hydrochloride (LFH). Both drugs and PLGA-PEG-PLGA copolymers could be easily dissolved in water at low or room temperature and the mixed solution could form a drug-loaded thermosensitive hydrogel in terms of body temperature response. The in vitro release investigation displayed a sustained release of MET and LFH from the formulation for one month. The in vivo efficacy of subconjunctival injection of the MET + LFH loaded thermosensitive hydrogel in inhibiting CNV was evaluated on a mouse model of corneal alkali burn. Compared with the single administration of MET or LFH loaded thermosensitive hydrogel, the MET + LFH loaded thermosensitive hydrogel remarkably inhibited the formation of CNV. The sustained release of MET and an antibiotic (LFH) provides synergistic therapeutic outcome. As a result, the co-delivery of MET and LFH using PLGA-PEG-PLGA thermosensitive hydrogel by subconjunctival injection has great potential for ocular anti-angiogenic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 2×
“Metformin (MET), a typical drug used for the treatment of type 2 diabetes, works by stimulating the adenosine 5’monophosphate (AMP)-activated protein kinase and influences the glucose uptake from the blood (Evans et al., 2005).”
BackgroundNormalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Injectable hydrogels as unique biomedical materials
Yu, L., & Ding, J. (2008) · Chemical Society Reviews · doi:10.1039/b713009k · Cited by 1,545
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406 · cited 1×
“The efficacy of local ocular drug delivery using thermosensitive hydrogel is much better than topical administration and conventional intraocular injection (Urtti, 2006; Gaudana et al., 2010), since the long-term drug release could efficiently inhibit the outgrowth of immature blood vessels.”
BackgroundChallenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Shen, W., Chen, X., Luan, J., Wang, D., Yu, L., & Ding, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11998 · Cited by 138 · cited 4×
“It might be attributed to the MET, which increases the antiangiogenic thrombospondin-1 (TSP-1) and decreases the level of VEGF receptor Flk-1 as well (Tan et al., 2009; Joe et al., 2015).”
BackgroundInfluential
Cited by
Wireless smart contact lens for diabetic diagnosis and therapy
Keum, D. H., Kim, S.-K., Koo, J., Lee, G.-H., Jeon, C., Mok, J. W., Mun, B. H., Lee, K. J., Kamrani, E., Joo, C.-K., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba3252 · Cited by 483
Recent Advances in Injectable Hydrogels for Controlled and Local Drug Delivery
Rizzo, F., & Kehr, N. S. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001341 · Cited by 378
Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy
Sun, H., Zhang, Q., Li, J., Peng, S., Wang, X., & Cai, R. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101073 · Cited by 332
In situ formation of injectable hydrogels for chronic wound healing
Gao, Y., Li, Z., Huang, J., Zhao, M., & Wu, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01074j · Cited by 189
Gu, W., Fan, R., Quan, J., Cheng, Y., Wang, S., Zhang, H., Zheng, A., & Song, S. (2022) · Polymers · doi:10.3390/polym14163368 · Cited by 25
Metadata
- Authors
- Liu, D., Wu, Q., Zhu, Y., Liu, Y., Xie, X., Li, S., Lin, H., Chen, W., & Zhu, F.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2019-01-01
- Volume
- 26
- Issue
- 1
- Pages
- 522-531
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2944987998
- Cited by
- 56
- References
- 6
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.